Investigation of maternal HEmodynamics and right ventricular function in PRegnant women with Tetralogy Of Fallot

Investigation of maternal HEmodynamics and right ventricular function in PRegnant women with Tetralogy Of Fallot - HEmodynamics in PRegnant women with Tetralogy Of Fallot

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48370

Enrollment

Registered

2019-02-13

Start date

2019-06-19

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease Tetralogy of Fallot

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients: pregnant before 20 weeks gestation, tetralogy of Fallot controls: pregnant before 20 weeks gestation

Exclusion criteria

Exclusion criteria: Patients: - Multiple gestation - Essential hypertension with or without proteinuria - History of organ transplantation - Concomitant disease - HELLP syndrome - Thrombocytopenia - Non hypertensive proteinuria and IUGR without associated maternal symptoms, Controls: - Chronic medication use - Under specialist control for chronic disease - Multiple gestation - Abnormal echocardiogram

Design outcomes

Primary

Measure	Time frame
I) Changes in maternal right ventricular function and cardiac output during pregnancy in women with ToF. II) Doppler investigation of the hepatic and renal veins and uterine arteries of pregnant women with ToF versus an equal number of healthy controls.	—

Countries

Netherlands

Outcome results